cambrianbio.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $149.86MM
Cambrian is a drug research and distribution company. With a mission to develop curative therapies for age-related diseases, Cambrian is partnering with clinical development researchers to help treat cellular dysfunction and tissue degeneration. Some programs included in the Cambrian pipeline include Telos Biotech, Tornado Therapeutics, and Amplifier Therapeutics. Cambrian was founded by Christian Angermayer, James Peyer, and Sebastian Brunemeier in 2019 and is headquartered in New York, New York.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cambrian.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.